Neue Perspektiven in der Behandlung des nicht kleinzelligen Lungenkarzinoms (NSCLC)

Publisher： Karger

E-ISSN： 2296-5262|29|2|25-28

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.2, 2006-09, pp. : 25-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Diagnostik des nicht kleinzelligen Lungenkarzinoms (NSCLC)

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 3-6

Karger

Access to resources Recommend Favorite

Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) im Stadium IV

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 15-19

Karger

Access to resources Recommend Favorite

Operation und adjuvante Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) (Stadium I bis operables IIIA)

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 7-10

Karger

Access to resources Recommend Favorite

Therapie des nicht kleinzelligen Lungenkarzinoms (NSCLC) im lokal fortgeschrittenen Stadium (inoperables IIIA/IIIB)

By  

Oncology Research and Treatment, Vol. 29, Iss. 2, 2006-09 ,pp. : 11-14

Karger

Access to resources Recommend Favorite

Docetaxel (Taxotere®) in der First-line-Therapie des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms (NSCLC)

By  

Oncology Research and Treatment, Vol. 26, Iss. 7, 2004-11 ,pp. : 26-32

Karger

Access to resources Recommend Favorite